Pill Identifier App

Ery Shield (Canada)

This page contains information on Ery Shield for veterinary use.
The information provided typically includes the following:
  • Ery Shield Indications
  • Warnings and cautions for Ery Shield
  • Direction and dosage information for Ery Shield

Ery Shield

This treatment applies to the following species:
Manufacturer: Novartis

Erysipelothrix Rhusiopathiae Bacterin

For Use In Animals Only

Ery Shield Indications

For use in healthy swine as an aid in the prevention of erysipelas caused by Erysipelothrix rhusiopathiae.

ADJUVANT: Aluminum hydroxide.

Directions For Use

Shake well before using. Administer 2 mL intramuscularly. Repeat in 21 days. Revaccinate annually or as recommended by your veterinarian.

Precautions

Store out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.

U.S. Vet. License No. 303

Novartis Animal Health US, Inc.

© 2007 Novartis; Registered trademark of Novartis AG.

Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9

1-800-387-6325

50 Doses

100 mL

117CA-01

250 Doses

500 mL

 

NAC No.: 12310774

NOVARTIS ANIMAL HEALTH CANADA INC.
2000 ARGENTIA RD., SUITE 400, PLAZA 3, MISSISSAUGA, ON, L5N 1V9
Telephone:   800-387-6325
Order Desk:   800-387-6325
Fax:   905-567-0221
Fax Orders:   800-827-5782
Website:   www.ah.novartis.ca
Email:   ah.questions@novartis.com
Every effort has been made to ensure the accuracy of the Ery Shield information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web5)